Search Orphan Drug Designations and Approvals
-
Generic Name: | fosfomycin/tobramycin |
---|---|
Date Designated: | 11/28/2008 |
Orphan Designation: | Treatment of pulmonary infections associated with cystic fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CURx Pharmaceuticals, Inc. 3210 Merryfield Row San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-